(Q33180329)

English

Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1 reference

Europe PubMed Central

Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

author name string

Eskens FA

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Verweij J

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Critical Reviews in Oncology Hematology

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

83-88

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900055-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Matrix metalloproteinase inhibitors: present achievements and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900055-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900055-X

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900055-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Farnesyl transferase inhibitors cause enhanced mitotic sensitivity to taxol and epothilones

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900055-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1040-8428(00)00055-X

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33180329&oldid=1537435388"